Texas Weight Loss Review: Questions to Settle Before Your First Visit

Before booking with Texas Weight Loss, the most useful question is not simply whether it offers GLP-1 medication. It does advertise injectable semaglutide and tirzepatide. The harder question is what your particular treatment arrangement would include: which formulation, supplied by whom, with what monitoring and at what combined cost. Its public documentation answers some of those questions concretely, including initial and follow-up visit prices, but leaves important connections between the clinic visit, prescription and medication supply unresolved.

This review examines public documentation consulted October 19, 2026, as preparation for a patient conversation rather than a treatment recommendation. Texas Weight Loss describes six Texas locations and a program combining medical assessment, nutrition support and monthly follow-up. That makes it more than a medication-ordering offer. Still, the documented semaglutide price is not an all-inclusive program price, and the pharmacy description does not identify the dispensing business. Those distinctions should shape the questions you ask before paying or agreeing to ongoing care.

At a glance

Clinic footprint: The provider says it has six Texas locations, with clinics in Austin, San Antonio and the Houston area.
Sources: [6] [3]
Initial visit: The advertised $150 initial visit includes consultation, specified laboratory work and body composition analysis; medication costs extra.
Sources: [9]
Follow-up: A monthly follow-up visit is advertised at $110, including consultation, an appetite-suppressant prescription if medically indicated and four energy-boosting shots.
Sources: [9]
Semaglutide price: Semaglutide is advertised at $100–$275 for a monthly supply depending on dosage, without establishing that visits or other charges are included.
Sources: [9]
Pharmacy disclosure: A Spanish-language page describes semaglutide sourced from a 503b compounding pharmacy but does not name that pharmacy.
Sources: [7]

Start by identifying the care arrangement you are actually booking

Texas Weight Loss presents itself as a medical weight-management business with 20 years of experience and six locations across Texas. Its FAQ identifies Austin, San Antonio and several Houston-area locations. The website also presents Joseph Sleiman with the credentials MD and FAAFP. These are provider statements, not independent verification of professional credentials, facility licensing or the operating legal entity. When scheduling, ask which location will manage your care and which clinician will conduct the initial assessment and subsequent visits.

The advertised starting point is a consultation at a clinic to discuss goals, review medical history and outline a personalized plan. Separately, the site advertises after-hours telemedicine exclusively for Texas residents. That residency restriction applies to the advertised service; it does not establish every geographic rule for the business. Nor does the announcement explain whether a new patient can complete the initial evaluation remotely, what after-hours access costs or how quickly someone responds.

For a patient, the practical issue is continuity between these services. Ask whether your regular clinic team also handles remote questions, whether appointments can move between locations and which route to use for a medication concern. The consulted documentation does not explain the relationship between Texas Weight Loss, the Texas Weight Loss Now name and the clinic45.com support-email domain. Clarifying the responsible business and care team is more useful than assuming those names are interchangeable.

Sources: [6] [3]

Ask what the assessment establishes—and what it does not

The GLP-1 program describes comprehensive evaluations to decide whether these medications may be appropriate. The first-visit description includes blood tests assessing liver, kidney and thyroid function, a medical consultation and body composition analysis. The pricing page names CMP, TSH, a lipid panel and HbA1c among the included tests. Ask how results are reviewed, whether an existing laboratory report can be used and whether any additional testing could generate a separate charge.

The FAQ also says an EKG is required for people with risk factors such as hypertension, diabetes or high cholesterol, and for those age 50 or older. The consulted pricing does not establish whether that test is included in the initial fee. This is a concrete reason to request an individualized previsit estimate rather than assuming the listed laboratory package covers every assessment the clinic might require.

Keep medication-specific criteria separate. Texas Weight Loss publishes a phentermine criterion of BMI at least 30 without a comorbid condition; that is not its documented GLP-1 eligibility policy. Its phentermine article also says certain people with heart disease, uncontrolled high blood pressure or a history of substance misuse may not be candidates. Full GLP-1 eligibility and minimum-age rules remain unclear. Bring a medication and supplement list and use these consultation questions to organize the discussion without treating an advertisement as a personal eligibility decision.

Sources: [8] [12] [3] [4] [9] [2]

Get the medicine’s identity in writing before comparing prices

Texas Weight Loss advertises injectable semaglutide and tirzepatide, and its Spanish-language semaglutide material describes subcutaneous administration. Another passage advertises semaglutide with glycine. These details matter because an ingredient name alone does not identify a finished product. The documentation does not establish that every semaglutide offering contains glycine, that the published price applies to that formulation or which manufacturer, concentration and presentation a patient would receive.

A Spanish-language page says the clinic obtains its in-house semaglutide from a 503b compounding pharmacy. It does not name the pharmacy or provide its location in that passage. Ask for the pharmacy’s identity, the precise formulation and who will dispense and label the medication. The provider’s claim that this arrangement supports quality and affordability is a commercial assertion, not independent confirmation of the product’s quality or equivalence to a branded medicine.

FDA approval belongs to specific products, not a clinic or an ingredient in every formulation. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality; that fact alone does not prove clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. The practical next step is to clarify exactly what medicine is offered, rather than assume the website’s general approval language covers the preparation you would receive.

Sources: [7] [11] [1]

Separate the appointment bill from the medication bill

The published $150 initial visit includes a medical consultation, the listed laboratory panel and body composition analysis. The same package lists four energy-boosting shots, a diet menu, a meal plan and a pantry makeover guide. Prescription eligibility is determined during the visit, and medication carries an additional charge. Paying for this assessment therefore does not establish that a prescription will be issued or that a month of medication is included.

The $110 monthly follow-up lists consultation, an appetite-suppressant medication prescription if medically indicated and four energy-boosting shots. A prescription is not the same as the supplied medicine. Separately, semaglutide costs $100–$275 for a monthly supply depending on dosage. The documentation does not connect that range to a specific formulation or establish an inclusive total. Tirzepatide pricing is not published in the consulted material, so its advertised availability cannot support a cost comparison.

Request a written estimate that distinguishes your first assessment, medication, recurring visits and any additional tests or supplies. Insurance acceptance, medication coverage, prior authorization help and payment methods are not explained in the consulted pages. Neither are automatic billing or the payment-collection schedule. The table below separates the published amounts without adding them into an unsupported treatment total; these questions beyond the monthly price can help expose the remaining variables.

Published charges are separate line items, not a verified all-inclusive GLP-1 package.
Item	Published charge	Important boundary
Initial weight-loss visit	$150	Listed consultation, labs, body composition and other package items; medication extra.
Monthly follow-up visit	$110	Includes a prescription if medically indicated, not a stated medication supply.
Semaglutide	$100–$275 per monthly supply	Depends on dosage; formulation and inclusion of other fees are not established.
Energy-boosting shots	$20 each or $60 for four	Also listed within visit packages; ask how separate purchases are handled.
“Fat Burner” shots and body composition	$25 per shot; $80 for four; $25 for separate body composition analysis	Four-shot listing carries a “buy three get one free” footnote without further terms in that block.

Sources: [9]

Find out how optional services fit your plan

The clinic’s offering extends beyond GLP-1 medicines. It advertises oral phentermine, supplements, vitamin B-6 injections and NAD+ injections according to personal needs. Its in-house intramuscular wellness-injection list includes glutathione, vitamin B12, Lipoden, L-proline, vitamin B1/B6, Plenish and an amino-acid mixture. These are documented offerings, not evidence that each is necessary for a GLP-1 patient or that an injection’s marketing name establishes a clinical benefit.

Texas Weight Loss says patients can choose not to take injections. Ask how that option applies to shots included in a visit package, whether declining them changes the price and whether the proposed plan depends on any separately purchased supplement. The FAQ also describes personalized meal plans reflecting lifestyle and food preferences, with menus and approved and unapproved food lists. Ask who develops that advice and whether follow-up includes revisiting a plan that is difficult to use.

The GLP-1 page says an individualized plan may include nutrition guidance, lifestyle recommendations, progress monitoring and medication management. The phrase “may include” leaves room for differences between patients; it does not promise every component at every visit. NIDDK describes weight-management medicines as accompanying healthy eating and physical activity rather than replacing them. For this provider, the useful question is how those services become a concrete, sustainable plan rather than a list of possible extras.

Sources: [8] [7] [10] [9] [3] [2]

Define follow-up as clinical access, not just a monthly appointment

The FAQ asks patients to return for monthly follow-up to track progress, explain results and adapt the plan. Spanish-language semaglutide material also says the team monitors treatment response and offers personalized help managing side effects. Those statements establish an intended monitoring role, but not the practical details of between-visit support. Ask which clinician reviews a concern, how to contact the team, what happens outside office hours and whether an extra consultation carries a separate charge.

The clinic’s safety messaging deserves clarification rather than a blanket reassuring interpretation. Its FAQ characterizes B12 and Lipoden as lacking important side effects, while other injection material acknowledges reactions, including allergic reactions. These are provider descriptions, not an independent clinical assessment. Ask for product-specific counseling about every proposed injection and distinguish the clinic’s marketing claims about glycine or rapid weight loss from evidence applicable to the actual preparation.

Do not assume the existence of after-hours telemedicine creates a round-the-clock response guarantee. Exact hours, fees, platform and response targets are not documented in the consulted material. Likewise, Spanish-language pages establish access to written Spanish information, not that every appointment or support channel operates in Spanish. These follow-up support questions are especially useful if you need a particular language, cannot easily return to the clinic or expect to travel during treatment.

Sources: [6] [3] [11] [5] [7]

Trace the handoff from prescription to medication at home

Texas Weight Loss says patients may administer injections at home after training from its medical team. That is a meaningful service detail, but the public documentation does not map the entire handoff. It does not establish whether medication is collected from a clinic, supplied directly by a pharmacy or shipped, nor does it describe delivery fees or arrival timing. Ask who provides the medicine, supplies and written instructions, and who resolves a missing or damaged order.

Training should be tied to the exact product and presentation dispensed, not merely the medication’s general name. FDA has received reports of measurement and administration errors involving compounded medication, some associated with hospitalization. Patients should clarify instructions with the prescriber or pharmacist rather than calculate an amount from a review. If an injectable GLP-1 shipment arrives warm or inadequately refrigerated, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy. This is general guidance, not evidence of a delivery problem at Texas Weight Loss.

Sources: [7] [3] [1]

Settle what happens after the first month

The provider documents monthly follow-up and a monthly semaglutide supply price, but those intervals do not establish a minimum commitment, automatic renewal or a cancellation policy. The consulted pages do not explain prepayment, missed-appointment fees, refunds or notice deadlines. Ask for those terms before paying, including what happens if the clinician does not prescribe, if you decide against injections or if medication is unavailable. Cancellation and refund rights are separate questions; neither can be inferred from an appointment schedule.

It is also worth distinguishing the clinical plan from the billing plan. NIDDK explains that treatment duration depends on response and side effects, and that obesity may require long-term care. Texas Weight Loss’s monthly monitoring description is compatible with reassessment, but does not explain a transition or discharge process. Ask who manages care if you stop attending, whether records can be transferred and how a change in treatment affects future charges. Clear answers would make the documented offer easier to evaluate without requiring a promise of results.

Sources: [3] [9] [2]

Questions & answers

Does the $150 initial visit include semaglutide?

No medication supply is included in the published description. The initial visit lists consultation, specified laboratory work, body composition analysis, four energy-boosting shots and nutrition materials. It expressly says medication is an additional charge and prescription eligibility is determined at the visit. Ask for a separate medication estimate before assuming the assessment fee covers treatment.

Sources: [9]

What does the $110 monthly follow-up include?

The listing includes a medical consultation, an appetite-suppressant prescription if medically indicated and four energy-boosting shots. It does not state that the medication itself is included. Semaglutide has a separate advertised monthly-supply range of $100–$275 depending on dosage. Confirm which charges apply to your proposed plan and whether additional testing or appointments would cost extra.

Sources: [9]

Is its advertised semaglutide a named FDA-approved product?

The consulted documentation does not establish that. It describes semaglutide with glycine and, separately, semaglutide obtained from an unnamed 503b compounding pharmacy. It does not connect every offering or price to one formulation. Ask for the exact product and dispensing pharmacy. Compounded preparations are not FDA approved, although nonapproval alone does not establish clinical inequivalence.

Sources: [11] [7] [1]

Can I use Texas Weight Loss entirely through telemedicine?

That is not established. The advertised program begins with a clinic consultation, while a separate announcement offers after-hours telemedicine exclusively to Texas residents. The documentation does not explain whether remote intake can replace the clinic visit, which services are available remotely or the associated fees. Confirm the arrangement directly rather than treating the announcement as a fully remote enrollment pathway.

Sources: [6] [3]

Do injections have to be given at the clinic?

The FAQ allows home self-administration after training by the medical team. It also says patients may choose not to take injections. Those statements do not establish which products are supplied for home use, how they are obtained or whether declining included wellness shots changes a package price. Ask the team to explain your specific arrangement and training process.

Sources: [3]

Does Texas Weight Loss accept insurance or promise refunds?

The consulted pages do not clarify insurance billing, prior authorization assistance, payment methods or refund terms. They also do not document automatic renewal, cancellation deadlines or minimum commitments. Missing documentation is not proof that these options or policies do not exist. Request written terms from the provider, and verify medication coverage separately with your health plan.

Sources: [9] [2]

Our assessment

Texas Weight Loss provides a reasonably concrete starting point for a clinic-based conversation: named service areas, published visit fees, specified initial testing, monthly monitoring and training for home injections. Its limitations concern the details that turn an advertised program into an accountable care arrangement. The pharmacy remains unnamed, the exact semaglutide formulation is not consistently tied to the price, and delivery, support access and financial exit terms need confirmation. A useful next step is a written, patient-specific explanation of the medicine, responsible clinician and pharmacy, complete charges and follow-up process—not an assumption that the lowest medication price represents the whole program.

Visit Texas Weight Loss’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Texas Weight Loss Review: Questions to Settle Before Your First Visit

At a glance

01Start by identifying the care arrangement you are actually booking

02Ask what the assessment establishes—and what it does not

03Get the medicine’s identity in writing before comparing prices

04Separate the appointment bill from the medication bill

05Find out how optional services fit your plan

06Define follow-up as clinical access, not just a monthly appointment

07Trace the handoff from prescription to medication at home

08Settle what happens after the first month

Questions & answers

Our assessment

Sources & documentation

Continue reading

Start by identifying the care arrangement you are actually booking

Ask what the assessment establishes—and what it does not

Get the medicine’s identity in writing before comparing prices

Separate the appointment bill from the medication bill

Find out how optional services fit your plan

Define follow-up as clinical access, not just a monthly appointment

Trace the handoff from prescription to medication at home

Settle what happens after the first month